Foundation contributes RM100k to genetic testing fund for cardiovascular diseases

Facebook
Twitter
WhatsApp
Telegram
Email
First cardiac contractility modulation (CCM) therapy implantation in South East Asia on 5 December 2022 for a patient with dilated cardiomyopathy due to Titin gene mutation.

KUCHING: Sarawak Heart Foundation (SHF) has contributed RM100,000 towards a fund for genetic testing for inherited cardiovascular disease at Sarawak Heart Centre (SHC).

The fund was set up in 2021 with RM50,000 from the SHF, and has benefitted 58 patients, including 8 children.

Last year, the genetic testing service was extended to children with inherited cardiovascular disease (mainly inherited aortopathies).

With another contribution of RM50,000 from the SHF last month, the SHC will be able to support more children.

Consultant cardiologist Dr Oon Yen Yee, who initiated the fund, said that the purpose of this fund is to subsidise or sponsor patients from the lower income group so that genetic testing is accessible to all.

Inherited cardiovascular disease is one that has been passed on through families. They can affect people of any age.

Dr Oon explained that symptoms reported by patients with inherited cardiovascular include palpitations, fainting spells, shortness of breath and chest pain.

In SHC, the most common inherited cardiovascular disease seen is hypertrophic cardiomyopathy (HCM).

HCM is a disease affecting the heart muscle, causing it to thicken abnormally.

See also  Lawyer collapses and dies at his firm

“Many patients with HCM under our care, are healthy individuals who display no symptoms. They are usually referred to SHC because of abnormal heart findings from a health check.

“Genetic testing can help to confirm the diagnosis of an inherited cardiovascular disease. Itcan also help to alleviate unnecessary anxiety among family members, because through genetic screening, those who do not carry the gene will not have the disease,” she said.

“However, not all patients with inherited cardiovascular disease will have a positive genetic test or a pathogenic mutation identified. There are patients where genetic testing only picks up a gene variant that is of “uncertain significance.”

Genetic testing has also allowed the doctors to provide individualised and targeted treatment for patients with inherited cardiovascular disease.

Dr Oon cited a case of a patient with heart failure due to Titin gene mutation. Her mother also suffers from heart failure and has passed down the gene to the patient. Because Titin mutation carries a better prognosis compared to other form of cardiomyopathy, the patient was offered cardiac contractility modulation (CCM) therapy.

See also  One community, two workplace clusters reported on Friday

CCM is a relatively new device-based therapy for patients with heart failure. The 2 treatment can help improve heart function.

He became the first patient to receive CCM therapy in Southeast Asia, and is now recovering and doing well.

The genetic tests at SHC are sent to a US-based company called INVITAE. The current cost of a genetic test is USD349 (RM1,605) per test.

Including transportation fees which ranges from RM150 to RM200, a patient would need to pay up to RM1,900 for a genetic test.

When a pathogenic mutation is detected in a patient, the company provides free testing to immediate family members, regardless of numbers.

Last year, SHC has started cardio genetic clinic service, making it the first cardiac centre in the Ministry of Health of Malaysia to establish cardio genetic clinic.

Dr Oon shares that patients often ask “Will a genetic test change the treatment of our heart disease?”

“Unfortunately, there is currently no cure for most of the inherited cardiovascular diseases. The treatment provided is mainly for symptom alleviation and prevention of sudden cardiac death. But there are studies examining treatment targeted at the mutated gene, and the findings showed promising results. In the future, these investigational treatments called gene therapy might offer a complete cure for inherited cardiovascular disease.”

See also  Dalat embraces digital economy, enhances literacy

Dr Oon also brought up the social implications when a person is tested positive for an inherited cardiovascular disease.

Those who are professional athletes will be advised to stop participating in competitive sports, hence affecting their career and income.

Insurance companies may impose certain restrictions or limit on their coverage. And the fear of passing down the gene to their offspring may hinder one from having a child.

“That is why we provide counselling before genetic testing, and when the results are out, another session of counselling will be arranged to explain the test results and the next course of action. We will try our best to help you and your family, so allow us to explain genetic testing to you when it is indicated. There may be no cure for the heart problem at present, but in the future, things might change.”

Download from Apple Store or Play Store.